|
TOP3A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.23360000495276E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.57210000573116E-09 |
| Normal-vs-Stage2 |
5.318000E-02 |
| Normal-vs-Stage3 |
1.175160E-03 |
| Normal-vs-Stage4 |
5.856800E-03 |
| Stage1-vs-Stage2 |
4.093600E-02 |
| Stage1-vs-Stage3 |
3.753200E-01 |
| Stage1-vs-Stage4 |
1.878590E-01 |
| Stage2-vs-Stage3 |
3.180400E-01 |
| Stage2-vs-Stage4 |
5.082800E-01 |
| Stage3-vs-Stage4 |
7.757400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.06149999959493E-07 |
| Normal-vs-AfricanAmerican |
1.216240E-03 |
| Normal-vs-Asian |
1.31969990491143E-11 |
| Caucasian-vs-AfricanAmerican |
6.582000E-01 |
| Caucasian-vs-Asian |
3.87860000000684E-05 |
| AfricanAmerican-vs-Asian |
2.46150000005052E-06 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.63796999999022E-05 |
| Normal-vs-Female |
1.30370003681435E-09 |
| Male-vs-Female |
3.754400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.588220E-01 |
| Normal-vs-Age(41-60Yrs) |
7.40719996450423E-09 |
| Normal-vs-Age(61-80Yrs) |
1.91468999999334E-05 |
| Normal-vs-Age(81-100Yrs) |
3.637400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.003600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.752600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.411600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.019900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.148210E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.335600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.53370005373921E-09 |
| Normal-vs-Grade 2 |
4.96080000411681E-08 |
| Normal-vs-Grade 3 |
3.92089999999845E-05 |
| Normal-vs-Grade 4 |
7.756900E-03 |
| Grade 1-vs-Grade 2 |
2.040200E-02 |
| Grade 1-vs-Grade 3 |
2.027900E-02 |
| Grade 1-vs-Grade 4 |
1.314440E-02 |
| Grade 2-vs-Grade 3 |
3.958400E-01 |
| Grade 2-vs-Grade 4 |
2.990800E-01 |
| Grade 3-vs-Grade 4 |
7.218800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.19279960645258E-10 |
| Normal-vs-ccB subtype |
8.416600E-04 |
| ccA subtype-vs-ccB subtype |
6.208100E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.62060000000286E-06 |
| Normal-vs-N1 |
9.681100E-03 |
| N0-vs-N1 |
2.911400E-01 |
|
|
